I prefer to buy before, rather than after FDA approval.
I don't find cash burn rate too bad and there are relatively few shares on issue so its not the end of the world if there's another CR.
Last week Bioshares rated GSS well on survival index (14th out of 90 biotech companies).
GSS Price at posting:
40.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)